Clinical Trial Update: Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 trial assessing the safety and efficacy of different once-daily formulations of bimatoprost in glaucoma or ocular h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED